GSK3B and neuroblastoma: Duffy et al. reported that a combined treatment with GSK-3β inhibitors like LiCl or BIO-acetoxime and a Wnt agonist induced death on neuroblastoma cells, downregulating c-myc and MYCN mRNA expression, regulating the p53 and Wnt/β-catenin pathways [270].